Global pharmaceutical industry contributes action plan and research to fighting NCDs in the developing world

Coinciding with the UN High-Level meeting on non-communicable diseases, the International Federation of Pharmaceutical Manufacturers released the following statement outlining steps they’re taking to address the growing global challenge of NCDs.

To coincide with the United Nations High-Level Meeting on NCDs, the research-based pharmaceutical industry today outlined the steps it is taking to address the rise of NCDs in the developing world. Building on its Framework for Action released earlier this year, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) revealed the findings of the first report of an independent policy research programme focused on identifying the most significant obstacles to stemming the tide of NCDs in developing countries.